Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Levy, J. C
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: UKPDS odyssey — 2001

Jonathan C Levy

Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology and Metabolism, The Radcliffe Infirmary, Woodstock Road, Oxford 0X2 6HE, jonathan.levy{at}drl.ox.ac.uk

The United Kingdom Prospective Diabetes Study, the most ambitious single study of the treatment and nature of type 2 diabetes to date has two and nature of type 2 diabetes to date has two aspects: (i) as a clinical trial it has established that intensified glucose and blood pressure control significantly reduce the micro- and macrovascular complications of type 2 diabetes; (ii) in addition, because of its size and duration and the density of the data collected, it provides unparalleled information on the nature and natural history of the disease. It has defined the major importance of hyperglycaemia and hypertension as risk factors for complications and with the trial results provides the rationale and the goals for therapy. However, identification of the progressive deterioration of beta-cell function and the relative inefficacy of currently available therapies has posed major challenges to the achievement of these goals. Like all classic studies it raises more questions for further investigation.

Key Words: type II diabetes • complications • microvascular • macrovascular • randomised controlled trial.

The British Journal of Diabetes & Vascular Disease, Vol. 1, No. 1, 14-21 (2001)
DOI: 10.1177/14746514010010010301
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
P. Jaiveer, J. Saraswathy, J. D Lee, J. Morrissey, and V. Patel
The Alphabet strategy -- a tool to achieve clinical trial standards in routine practice?
The British Journal of Diabetes & Vascular Disease, November 1, 2003; 3(6): 410 - 413.
[Abstract] [PDF]